As Natalia comments in the panel entitled “How can life science technology providers support the pharmaceutical industry in the transition toward more digitally connected operations?”, manufacturing equipment and tools are increasingly digital and automated, aiming to boost productivity, reproducibility, cost-effectiveness, and sustainability. Natalia states how VIVEbiotech is contributing to this shift by leveraging big data, AI, and robotics, viewing the digital transition as a strategic, multidisciplinary project.

In addition to Natalia’s contribution from VIVEbiotech, the roundtable includes various experts from several companies such as TriRx Pharmaceutical Services, LLC, GBI Bio, Quotient Sciences, Nu-Tek BioSciences, Mikart, LLC, Oxford Biomedica, PCI Pharma Services, Samsung Biologics, SCIEX, Cytiva, Cambrex, Astrea Bioseparations, BioIVT, LabVantage Solutions, Inc, Lonza, SK pharmteco, Thermo Fisher Scientific, OM1, Inc., Bruker BioSpin, MilliporeSigma, Certara, eClinical Solutions, ProPharma, ScaleReady, Green Elephant Biotech, Likarda, Terumo Blood and Cell Technologies, NextCell Pharma AB, OrganoBiotech, Inc., and IDBS.

You can read the full article here:

Thanks a lot to Pharma’s Almanac for this excellent opportunity.